Jai Patel is Chief Medical Officer of Imbria Pharmaceuticals. Dr. Patel has over 25 years of experience in Phase I to IV clinical drug development in the US and Europe in the cardiovascular and metabolism therapeutic area. Prior to Imbria, Dr. Patel was the Chief Medical Officer at Enterome and NephroGenex. Dr. Patel spent over 20 years at GlaxoSmithKline in positions of increasing responsibility, serving as Vice President across multiple R&D functions including Clinical Development, Medical Affairs and Regulatory Affairs. Dr. Patel received a Bachelor of Science in Experimental Pathology from the University of London and completed his medical training at St. Bartholomew’s Hospital and Kings College Hospitals, University of London. Dr. Patel is a member of the Royal College of Physicians (UK).